308 related articles for article (PubMed ID: 23377410)
21. Fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) for the detection of skeletal muscle and skin metastases in uterine leiomyosarcoma: a case report.
Ozdemir E; Poyraz NY; Uzun B; Türkölmez S
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):257-9. PubMed ID: 23153988
[TBL] [Abstract][Full Text] [Related]
22. [Positron emission tomography with 18F-fluorodeoxyglucose in patients with uterine sarcoma].
Rebollo Aguirre AC; Ramos Font C; Bellón Guardia ME; Cabello García D; Gallego Peinado M; Rodríguez Fernández A; Llamas Elvira JM
Rev Esp Med Nucl; 2007; 26(4):189-95. PubMed ID: 17662185
[TBL] [Abstract][Full Text] [Related]
23. Clinical staging of patients with early esophageal adenocarcinoma: does FDG-PET/CT have a role?
Cuellar SL; Carter BW; Macapinlac HA; Ajani JA; Komaki R; Welsh JW; Lee JH; Swisher SG; Correa AM; Erasmus JJ; Hofstetter WL
J Thorac Oncol; 2014 Aug; 9(8):1202-6. PubMed ID: 25157774
[TBL] [Abstract][Full Text] [Related]
24. Proposal of a new acquisition protocol for bladder cancer visualization with 18F-FDG PET/CT.
Chondrogiannis S; Marzola MC; Colletti PM; Rubello D
Clin Nucl Med; 2015 Jan; 40(1):e78-80. PubMed ID: 24566416
[TBL] [Abstract][Full Text] [Related]
25. Value of 18F-FDG PET/CT imaging in the staging, restaging, monitoring of response to therapy and surveillance of uterine leiomyosarcomas.
Bélissant O; Champion L; Thevenet H; Weinmann P; Alberini JL
Nucl Med Commun; 2018 Jul; 39(7):652-658. PubMed ID: 29683931
[TBL] [Abstract][Full Text] [Related]
26. Comparison of 11C-choline with 18F-FDG in positron emission tomography/computerized tomography for staging urothelial carcinoma: a prospective study.
Golan S; Sopov V; Baniel J; Groshar D
J Urol; 2011 Aug; 186(2):436-41. PubMed ID: 21679983
[TBL] [Abstract][Full Text] [Related]
27. Diuretic 18F-Fluorodeoxyglucose PET/Computed Tomography in Evaluation of Genitourinary Malignancies.
Agarwal KK; Roy SG; Kumar R
PET Clin; 2016 Jan; 11(1):39-46. PubMed ID: 26590442
[TBL] [Abstract][Full Text] [Related]
28. Apocrine sweat gland carcinoma: initial evaluation, staging, and response monitoring using 18F-FDG PET/CT.
Singh H; Sharma P; Suman Kc S; Bal C; Malhotra A; Julka PK; Kumar R
Clin Nucl Med; 2013 May; 38(5):e223-5. PubMed ID: 23377411
[TBL] [Abstract][Full Text] [Related]
29. Catheter-assisted 18F-FDG-PET/CT imaging of primary bladder cancer: a prospective study.
Mertens LS; Bruin NM; Vegt E; de Blok WM; Fioole-Bruining A; van Rhijn BW; Horenblas S; Vogel WV
Nucl Med Commun; 2012 Nov; 33(11):1195-201. PubMed ID: 22781846
[TBL] [Abstract][Full Text] [Related]
30. PET/Computed Tomography in Renal, Bladder, and Testicular Cancer.
Bouchelouche K; Choyke PL
PET Clin; 2015 Jul; 10(3):361-74. PubMed ID: 26099672
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients.
Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Pinker-Domenig K; Berzaczy D; Hoffmann M; Sillaber C; Jaeger U; Müllauer L; Simonitsch-Klupp I; Dolak W; Gaiger A; Ubl P; Lukas J; Raderer M
Clin Cancer Res; 2014 Jun; 20(11):2984-93. PubMed ID: 24696320
[TBL] [Abstract][Full Text] [Related]
32. Extrarenal malignant rhabdoid tumor in childhood application of 18F-FDG PET/CT.
Howman-Giles R; McCowage G; Kellie S; Graf N
J Pediatr Hematol Oncol; 2012 Jan; 34(1):17-21. PubMed ID: 22052165
[TBL] [Abstract][Full Text] [Related]
33. ¹⁸F-FDG-PET/CT in initial staging and assessment of early response to chemotherapy of pediatric rhabdomyosarcomas.
Eugene T; Corradini N; Carlier T; Dupas B; Leux C; Bodet-Milin C
Nucl Med Commun; 2012 Oct; 33(10):1089-95. PubMed ID: 22929116
[TBL] [Abstract][Full Text] [Related]
34. Fluorodeoxyglucose positron-emission tomography (FDG PET)/computed tomography (CT) in bladder cancer.
Goh V; Cook G
BJU Int; 2013 Oct; 112(6):709. PubMed ID: 24028759
[No Abstract] [Full Text] [Related]
35. Combined PET/CT by 18F-FDOPA, 18F-FDA, 18F-FDG, and MRI correlation on a patient with Carney triad.
Papadakis GZ; Patronas NJ; Chen CC; Carney JA; Stratakis CA
Clin Nucl Med; 2015 Jan; 40(1):70-2. PubMed ID: 25423347
[TBL] [Abstract][Full Text] [Related]
36. Utility of 18F-FDG PET/CT in diagnosis and management of mucormycosis.
Liu Y; Wu H; Huang F; Fan Z; Xu B
Clin Nucl Med; 2013 Sep; 38(9):e370-1. PubMed ID: 23531773
[TBL] [Abstract][Full Text] [Related]
37. A Case of Mediastinal Leiomyosarcoma Demonstrated on FDG PET/CT Imaging.
Wu X; Huang Y; Li Y; Wang H; Jiang L
Clin Nucl Med; 2019 Mar; 44(3):e158-e160. PubMed ID: 30624267
[TBL] [Abstract][Full Text] [Related]
38. Editorial comment on: FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
Sherif A
Eur Urol; 2010 Apr; 57(4):647. PubMed ID: 19477582
[No Abstract] [Full Text] [Related]
39. Multiple leiomyosarcoma foci in 18F-FDG PET-CT.
Sürücü E; Aslan M; Karahan P; Durak H
Rev Esp Med Nucl Imagen Mol; 2013; 32(4):269-70. PubMed ID: 23122743
[No Abstract] [Full Text] [Related]
40. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
